§ 12-6a-06

(a) A protocol under this subtitle: (1) May authorize: (i) For protocols by a licensed physician and licensed pharmacist, the initiation of drug therapy under written, disease–state specific protocols; (ii) The modification, continuation, and discontinuation of drug therapy under written, disease–state specific protocols; (iii) The ordering of laboratory tests; and (iv) Other patient care management measures related to monitoring or improving the outcomes of drug or device therapy; and (2) May not authorize acts that exceed the scope of practice of the parties to the therapy management contract. (b) A protocol shall prohibit the substitution of a chemically dissimilar drug product by the pharmacist for the product prescribed by the authorized prescriber, unless permitted in the therapy management contract.